Pestalozzi advises H.C. Wainwright in connection with private placement in NLS Pharmaceutics Ltd | Pestalozzi Attorneys at Law

Pestalozzi advises H.C. Wainwright in connection with private placement in NLS Pharmaceutics Ltd

Print

Pestalozzi advised H.C. Wainwright LLC in connection with a direct offering of 7,000,000 common shares in NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company listed at NASDAQ (Ticker: NLSP/NLSPW) and in a private placement warrants to purchase up to 3'500'000 common shares. H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering.

Pestalozzi advised H.C. Wainwright & Co. LLC as to all matters of Swiss law.

Pestalozzi Attorneys at Law Ltd.
Zurich – Feldeggstrasse 4 | 8008 Zurich | Switzerland | T +41 44 217 91 11
Geneva – Cours de Rive 13 | 1204 Geneva | Switzerland | T +41 22 999 96 00
www.pestalozzilaw.com

To the top